Abstract
Purpose
To evaluate vitreoretinal interface anomalies over time in patients diagnosed with toxoplasmosis retinochoroiditis (TRC) and progression of the chronic disease.
Study design
Retrospective clinical study.
Methods
The clinical records of 36 patients with TRC were studied retrospectively. All patients underwent standard ophthalmological examinations and optical coherence tomography (optical coherence tomography: OCT). Vitreoretinal interface changes and retinal layers in the macula and lesion area were evaluated.
Results
The fovea was involved in 9 (25%) patients. OCT of the scar region showed retinal layer thinning and disorganization in all cases. Complete posterior vitreous detachment (PVD) was detected in 9 (25%) cases, incomplete PVD in 22 (61%) cases and no PVD in 5 (13.8%) cases. In 23 (63%) of the 36 patients with inactive TRC lesions, an epiretinal membrane (ERM) was detected by follow-up OCT, i.e., in 14 (60%) patients with incomplete PVD, 8 (34.7%) with complete PVD, and 1 (4%) with no PVD. Vitreoschisis was found in 5 of 22 patients with incomplete PVD; an ERM developed in 4 of these 5 patients. No ERM developed only in the macula, i.e., independent of the TRC scar region.
Conclusions
Vitreoretinal interface anomalies are common in patients diagnosed with TRC, including those with incomplete PVD. We observed no progression of vitreoretinal interface anomalies during the follow-up of patients diagnosed with TRC.
Similar content being viewed by others
References
McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121:35–46.
Pavesio C, Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol. 1996;80:1099–107.
Branson SV, McClafferty BR, Kurup SK. Vitrectomy for epiretinal membranes and macular holes in uveitis patients. J Ocul Pharmacol Ther. 2017;33:298–303.
Öztürk HE, Yücel ÖE, Süllü. Vitreomacular interface disorders in Behçet’s uveitis. Turk J Ophthalmol. 2017;47:261–6.
Gallagher MJ, Yilmaz T, Cervantes- Castaneda RA, Foster CS. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91:1680–5.
Guagnini AP, De Potter P, Levecq L, Kozyreff A. Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. Graefes Arch Clin Exp Ophthalmol. 2007;245:158–60.
Diniz B, Regatieri C, Andrade R, Maia A. Evaluation of spectral domain and time domain optical coherence tomography findings in toxoplasmic retinochoroiditis. Clin Ophthalmol. 2011;5:645–50.
Oréfice JL, Costa RA, Oréfice F, Campos W, Cost- Lima D, Scott IU. Vitreoretinal morphology in active ocular toxoplasmosis: a prospective study by optical coherence tomography. Br J Ophthalmol. 2007;91:773–80.
Maitra P, Kumar DA, Agarwal A. Epiretinal membrane profile on spectral domain optical coherence tomography in patients with uveitis. Indian J Ophthalmol. 2019;67:376–81.
Duker JS, Kaiser PK, Binder S, Smet MD, Gaudric A, Reichel E, Sadda SR, Sebag J, Spaide RF, Stalmans P. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611–9.
Oréfice JL, Costa RA, Campos W, Calucci D, Scott IU. Oréfice F. Third-generation optical coherence tomography findings in punctate retinal toxoplasmosis. Am J Ophthalmol. 2006;142:503–5.
Tsukahara M, Mori K, Gehlbach PL, Mori K. Posterior vitreous detachment as observed by wide-angle OCT imaging. Ophthalmology. 2018;125:1372–83.
Munk MR, Ram R, Rademaker A, Liu D, Setlur V, Chau F, Erfuth US, Goldstein DA. Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema. Acta Ophthalmol. 2015;93:e561-7.
Seth A, Raina UK, Thirumalai S, Batta S, Ghosh B. Full-thickness macular hole in Bartonella henselae neuroretinitis in an 11-year-old girl. Oman J Ophthalmol. 2015;8:44–6.
Gregory ME, Bhatt U, Benskin S, Banerjee S. Bilateral full thickness macular holes in association with serpiginous choroiditis. Ocul Immunol Inflamm. 2009;17:328–9.
Bringmann A, Wiedemann P. Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol. 2009;247:865–83.
Joshi M, Agrawal S, Christoforidis JB. Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediators Inflamm 2013;192582. https://doi.org/10.1155/2013/192582.
Hiscott P, Hagan S, Heathcote L, Sheridan CM, Groenewald CP, Grierson I, Wong D, Paraoan L. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye. 2002;16:393–403.
Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment, (4th edn.), Mosby, St. Louis, 1997; pp. 58–165.
Fraser-Bell S, Guzowski M, Rochchina E, Wang JJ, Mitchell P. Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology. 2003;110:34–40.
Aleixo ALQC, Curi ALL, Benchimol EI, Amendoeira MRR. Toxoplasmic retinochoroiditis: clinical characteristics and visual outcome in a prospective study. PLoS Negl Trop Dis. 2016;10:e0004685.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
S. K. Adıyeke, None; G. Ture, None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Corresponding author: Seda Karaca Adıyeke
About this article
Cite this article
Karaca Adıyeke, S., Ture, G. Vitreoretinal interface anomalies in patients with a history of toxoplasmosis retinochoroiditis. Jpn J Ophthalmol 66, 320–325 (2022). https://doi.org/10.1007/s10384-022-00912-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-022-00912-5